Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 11,006 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · derivative · entry 9 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 11,006 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 17,053 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · derivative · entry 8 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,454 Underlying: Common shares · 17,053 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Tax withholdingCommon shares without par value | 24,269 | $53.12 | $1,289,169.28 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · nonDerivative · entry 3 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,819 Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 11,006 | $41.64 | $458,318.46 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 17,053 | $41.03 | $699,713.58 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2007 Filed Aug 6, 2007 22:19 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 7,156 | $0.00 Strike: $51.21 | $0.00 |
DisclosureSEC source: 0001104659-07-059282 · a4.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,156 Underlying: Common Shares · 7,156 shares Expires 2014-08-02 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 03, 2007 Filed Aug 6, 2007 22:19 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 8,333 | $0.00 Strike: $39.26 | $0.00 |
DisclosureSEC source: 0001104659-07-059282 · a4.xml · derivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 8,333 shares Expires 2014-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 03, 2007 Filed Aug 6, 2007 22:19 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 7,156 | $51.21 | $366,458.76 |
DisclosureSEC source: 0001104659-07-059282 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,552 Read SEC document |
| August 03, 2007 Filed Aug 6, 2007 22:19 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 8,333 | $39.26 | $327,153.58 |
DisclosureSEC source: 0001104659-07-059282 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2007 Filed Aug 6, 2007 21:27 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 4,549 | $0.00 Strike: $50.95 | $0.00 |
DisclosureSEC source: 0001104659-07-059246 · a4.xml · derivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,549 Underlying: common shares · 4,549 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 02, 2007 Filed Aug 6, 2007 21:27 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 11,156 | $0.00 Strike: $50.95 | $0.00 |
DisclosureSEC source: 0001104659-07-059246 · a4.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,156 Underlying: common shares · 11,156 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 02, 2007 Filed Aug 6, 2007 21:27 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,763 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-059246 · a4.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 5,763 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 02, 2007 Filed Aug 6, 2007 21:27 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 14,258 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-059246 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 14,258 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 02, 2007 Filed Aug 6, 2007 21:27 UTC |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 15,705 | $50.95 | $800,169.75 |
DisclosureSEC source: 0001104659-07-059246 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,452 Read SEC document |
| August 02, 2007 Filed Aug 6, 2007 21:27 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,763 | $33.23 | $191,512.56 |
DisclosureSEC source: 0001104659-07-059246 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2007 Filed Aug 6, 2007 21:27 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 14,258 | $34.77 | $495,789.16 |
DisclosureSEC source: 0001104659-07-059246 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 20:20 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 22,000 | $0.00 Strike: $50.74 | $0.00 |
DisclosureSEC source: 0001104659-07-058354 · a4.xml · derivative · entry 3 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Shares · 22,000 shares Expires 2017-07-31 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 7,334 on 08/01/2008, 7,333 on 08/01/2009, and 7,333 on 08/01/2010. Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 20:20 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantCommon shares without par value | 4,000 | $50.74 | $202,960.00 |
DisclosureSEC source: 0001104659-07-058354 · a4.xml · nonDerivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,800 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 20:20 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantCommon shares without par value | 5,400 | $50.74 | $273,996.00 |
DisclosureSEC source: 0001104659-07-058354 · a4.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,800 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 20:22 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 1,381 | $50.69 | $70,002.89 |
DisclosureSEC source: 0001104659-07-058357 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,375 Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 22:58 UTC |
REYNOLDS W ANNDirector
|
Exercise / conversionOption (right to buy) · Derivative | 2,881 | $0.00 Strike: $30.20 | $0.00 |
DisclosureSEC source: 0001104659-07-058452 · a4.xml · derivative · entry 7 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,881 shares Expires 2007-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 22:58 UTC |
REYNOLDS W ANNDirector
|
Exercise / conversionOption (right to buy) · Derivative | 1,436 | $0.00 Strike: $30.24 | $0.00 |
DisclosureSEC source: 0001104659-07-058452 · a4.xml · derivative · entry 6 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,436 shares Expires 2007-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 22:58 UTC |
REYNOLDS W ANNDirector
|
Tax withholdingCommon shares without par value | 2,572 | $50.69 | $130,374.68 |
DisclosureSEC source: 0001104659-07-058452 · a4.xml · nonDerivative · entry 3 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,477 Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 22:58 UTC |
REYNOLDS W ANNDirector
|
Exercise / conversionCommon shares without par value | 2,881 | $30.20 | $86,994.10 |
DisclosureSEC source: 0001104659-07-058452 · a4.xml · nonDerivative · entry 2 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2007 Filed Aug 2, 2007 22:58 UTC |
REYNOLDS W ANNDirector
|
Exercise / conversionCommon shares without par value | 1,436 | $30.24 | $43,428.66 |
DisclosureSEC source: 0001104659-07-058452 · a4.xml · nonDerivative · entry 1 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 20:05 UTC |
Schumacher Laura JExecutive V.P. , Gen Cnsl, Sec
|
GrantOption (right to buy) · Derivative | 12,114 | $0.00 Strike: $50.03 | $0.00 |
DisclosureSEC source: 0001104659-07-057895 · a4.xml · derivative · entry 10 Schumacher Laura J · CIK 0001319245 · Executive V.P. , Gen Cnsl, Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,114 Underlying: Common shares · 12,114 shares Expires 2013-08-31 F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 20:05 UTC |
Schumacher Laura JExecutive V.P. , Gen Cnsl, Sec
|
GrantOption (right to buy) · Derivative | 312 | $0.00 Strike: $50.03 | $0.00 |
DisclosureSEC source: 0001104659-07-057895 · a4.xml · derivative · entry 9 Schumacher Laura J · CIK 0001319245 · Executive V.P. , Gen Cnsl, Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312 Underlying: Common shares · 312 shares Expires 2013-02-13 F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 20:05 UTC |
Schumacher Laura JExecutive V.P. , Gen Cnsl, Sec
|
Exercise / conversionOption (right to buy) · Derivative | 12,538 | $0.00 Strike: $37.59 | $0.00 |
DisclosureSEC source: 0001104659-07-057895 · a4.xml · derivative · entry 8 Schumacher Laura J · CIK 0001319245 · Executive V.P. , Gen Cnsl, Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 12,538 shares Expires 2013-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 20:05 UTC |
Schumacher Laura JExecutive V.P. , Gen Cnsl, Sec
|
Exercise / conversionOption (right to buy) · Derivative | 14,595 | $0.00 Strike: $37.59 | $0.00 |
DisclosureSEC source: 0001104659-07-057895 · a4.xml · derivative · entry 7 Schumacher Laura J · CIK 0001319245 · Executive V.P. , Gen Cnsl, Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 14,595 shares Expires 2013-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 20:05 UTC |
Schumacher Laura JExecutive V.P. , Gen Cnsl, Sec
|
Exercise / conversionOption (right to buy) · Derivative | 2,314 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-057895 · a4.xml · derivative · entry 6 Schumacher Laura J · CIK 0001319245 · Executive V.P. , Gen Cnsl, Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: Common shares · 2,314 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 20:05 UTC |
Schumacher Laura JExecutive V.P. , Gen Cnsl, Sec
|
SaleCommon shares without par value | 17,021 | $50.40 | $857,936.70 |
DisclosureSEC source: 0001104659-07-057895 · a4.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Executive V.P. , Gen Cnsl, Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,524 Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 20:05 UTC |
Schumacher Laura JExecutive V.P. , Gen Cnsl, Sec
|
Tax withholdingCommon shares without par value | 12,426 | $50.03 | $621,672.78 |
DisclosureSEC source: 0001104659-07-057895 · a4.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive V.P. , Gen Cnsl, Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,545 Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 20:05 UTC |
Schumacher Laura JExecutive V.P. , Gen Cnsl, Sec
|
Exercise / conversionCommon shares without par value | 27,133 | $37.59 | $1,019,986.45 |
DisclosureSEC source: 0001104659-07-057895 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive V.P. , Gen Cnsl, Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 20:05 UTC |
Schumacher Laura JExecutive V.P. , Gen Cnsl, Sec
|
Exercise / conversionCommon shares without par value | 2,314 | $33.23 | $76,897.46 |
DisclosureSEC source: 0001104659-07-057895 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive V.P. , Gen Cnsl, Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 21:34 UTC |
Michael Edward L.Executive Vice President
|
GrantOption (right to buy) · Derivative | 22,000 | $0.00 Strike: $50.52 | $0.00 |
DisclosureSEC source: 0001104659-07-057986 · a4.xml · derivative · entry 3 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Shares · 22,000 shares Expires 2017-07-29 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 7,334 on 07/30/2008, 7,333 on 07/30/2009, and 7,333 on 07/30/2010. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 21:34 UTC |
Michael Edward L.Executive Vice President
|
GrantCommon shares without par value | 20,000 | $50.52 | $1,010,400.00 |
DisclosureSEC source: 0001104659-07-057986 · a4.xml · nonDerivative · entry 2 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,331 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. This award generally will vest 29 months from the date of grant and include the right to have stock withheld for tax purposes. Read SEC document |
| July 30, 2007 Filed Aug 1, 2007 21:34 UTC |
Michael Edward L.Executive Vice President
|
GrantCommon shares without par value | 5,400 | $50.52 | $272,808.00 |
DisclosureSEC source: 0001104659-07-057986 · a4.xml · nonDerivative · entry 1 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,331 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| June 30, 2007 Filed Jul 3, 2007 18:28 UTC |
DALEY WILLIAM MDirector
|
GrantStock equivalent units · Derivative | 423 | $53.55 Strike: $0.00 | $22,651.65 |
DisclosureSEC source: 0001104659-07-052109 · a4.xml · derivative · entry 1 DALEY WILLIAM M · CIK 0001183865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,777 Underlying: common shares · 423 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2007 Filed Jul 3, 2007 18:27 UTC |
Tyree James LSenior Vice President
|
Tax withholdingCommon shares without par value | 3,945 | $53.55 | $211,254.75 |
DisclosureSEC source: 0001104659-07-052107 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,652 Read SEC document |
| June 30, 2007 Filed Jul 3, 2007 18:30 UTC |
FULLER H LAURANCEDirector
|
GrantStock equivalent units · Derivative | 479 | $53.55 Strike: $0.00 | $25,650.45 |
DisclosureSEC source: 0001104659-07-052110 · a4.xml · derivative · entry 1 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,682 Underlying: common shares · 479 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2007 Filed Jul 3, 2007 18:32 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 264 | $53.55 Strike: $0.00 | $14,137.20 |
DisclosureSEC source: 0001104659-07-052112 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,865 Underlying: common shares · 264 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2007 Filed Jul 3, 2007 18:33 UTC |
SCOTT SAMUEL C IIIDirector
|
GrantStock equivalent units · Derivative | 317 | $53.55 Strike: $0.00 | $16,975.35 |
DisclosureSEC source: 0001104659-07-052113 · a4.xml · derivative · entry 1 SCOTT SAMUEL C III · CIK 0001202862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317 Underlying: common shares · 317 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. Read SEC document |
| June 30, 2007 Filed Jul 3, 2007 18:35 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock equivalent units · Derivative | 507 | $53.55 Strike: $0.00 | $27,149.85 |
DisclosureSEC source: 0001104659-07-052115 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,376 Underlying: common shares · 507 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2007 Filed Jul 3, 2007 18:36 UTC |
TILTON GLENN FDirector
|
GrantStock equivalent units · Derivative | 317 | $53.55 Strike: $0.00 | $16,975.35 |
DisclosureSEC source: 0001104659-07-052119 · a4.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317 Underlying: common shares · 317 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC |
Patton Donald V JRSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,909 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 12 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,909 Underlying: common shares · 1,909 shares Expires 2013-02-13 F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC |
Patton Donald V JRSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,640 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 11 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,193 Underlying: common shares · 2,640 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC |
Patton Donald V JRSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,762 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 10 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,762 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC |
Patton Donald V JRSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 4,921 | $0.00 Strike: $43.70 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 9 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 4,921 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC |
Patton Donald V JRSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,778 | $0.00 Strike: $48.37 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 8 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,778 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC |
Patton Donald V JRSenior Vice President
|
SaleCommon shares without par value | 9,192 | $54.25 | $498,675.19 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 6 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,107 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.